Influenza Diagnostics Market Revenue to increase at 7.80% CAGR, to reach USD 954.512 million By 2023, Says Market Research Future

    NEXT STORY
    Progenics Pharmaceuticals Announces Agreement with FUJIFILM Toyama Chemical Co. for Automated Bone Scan Index (aBSI) Product in Japan
    PREV STORY
    Global Fluoroscopy Equipment Market Analysis & Forecast to 2024 – Focus on Fixed C-arms, Fluoroscopy Systems, Remote Controlled, Mobile C-arms
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ContraFect’s Exebacase (CF-301) Improved Clinical Outcomes in Staphylococcus aureus Bacteremia including  Right-Sided Endocarditis Compared to Standard of Care Antibiotics Alone in a First-in-Patient Phase 2 Superiority Study

    Proof of concept that new class of lysin biologics has the potential to improve ...

    author_avatar
    NASDAQ Market News

    Oncolytics Biotech® Has Applied to List its Common Shares on Nasdaq and Announces Share Consolidation

    CALGARY, Alberta and SAN DIEGO, May 22, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. ...

    author_avatar
    NASDAQ Market News

    ContraVir to Highlight New Data at EASL The International Liver Congress™ 2017 in Amsterdam, The Netherlands

    MEDIA ADVISORY, April 11, 2017 (GLOBE NEWSWIRE) -- WHAT: Tenofovir Exalidex (TXL™) is ContraVir’s ...

    author_avatar
    NASDAQ Market News